UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain

The American journal of gastroenterology, 2015-05, Vol.110 (5), p.725-732

2015

Volltextzugriff (PDF)

Evaluation of guideline-adherent treatment in cluster headache

Cephalalgia, 2016-07, Vol.36 (8), p.760-764

2016

Volltextzugriff (PDF)

Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-label, Phase 3b/4 Trial

Pain practice, 2016-06, Vol.16 (5), p.600-619

2016

Volltextzugriff (PDF)

New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects

Pain medicine (Malden, Mass.), 2015-08, Vol.16 (8), p.1540-1550

2015

Volltextzugriff (PDF)

Changes in Health-Related Quality of Life in Patients with Therapy-Resistant Migraine during Treatment with Erenumab in an Ambulatory Care Setting

Journal of clinical medicine, 2023-08, Vol.12 (17), p.5619

2023

Volltextzugriff (PDF)

Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial

Lancet neurology, 2021-01, Vol.20 (1), p.29-37

2021

Volltextzugriff (PDF)

Cistus incanus (CYSTUS052) for treating patients with infection of the upper respiratory tract. A prospective, randomised, placebo-controlled clinical study

Antiviral research, 2009-12, Vol.84 (3), p.267-271

2009

Volltextzugriff (PDF)

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

Pain (Amsterdam), 2008-07, Vol.137 (2), p.428-440

2008

Volltextzugriff (PDF)

Schmerz lass nach: Eine Einführung in die moderne Schmerztherapie

Praxis Handreha, 2024-04, Vol.5 (2), p.56-61

Jansen, Jan-Peter

2024

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/012) of Alvimopan for Opioid-Induced Bowel Dysfunction in Patients With Non-Cancer Pain

The journal of pain, 2011-02, Vol.12 (2), p.185-193

2011

Volltextzugriff (PDF)

A Randomized, Blind Comparison of Remifentanil and Alfentanil During Anesthesia for Outpatient Surgery

Anesthesia and analgesia, 1997-11, Vol.85 (5), p.1014-1019

1997

Volltextzugriff (PDF)

Survey to evaluate diagnosis and management of headache in primary care: Headache Management Pattern programme

Current medical research and opinion, 2008-12, Vol.24 (12), p.3413-3422

2008

Volltextzugriff (PDF)

Efficacy, Tolerability and Safety of Oral Eletriptan and Ergotamine plus Caffeine (Cafergot®) in the Acute Treatment of Migraine: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Comparison

European neurology, 2002-01, Vol.47 (2), p.99-107

2002

Volltextzugriff (PDF)

Real-world evidence on HRQoL of therapy-resistant migraine patients undergoing preventive treatment in an ambulatory care setting (P1-1.Virtual)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: Results of a twelve‐week, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study

Arthritis and rheumatism, 2010-01, Vol.62 (1), p.291-300

2010

Volltextzugriff (PDF)

Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design

Cephalalgia, 2012-07, Vol.32 (10), p.750-765

2012

Volltextzugriff (PDF)

An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study

Journal of headache and pain, 2019-03, Vol.20 (1), p.26-26, Article 26

2019

Volltextzugriff (PDF)

Kapitel 12 - Somatic Symptom Disorder – die somatische Belastungsstörung

Schmerzmedizin kompakt, 2023, p.89-90

Jansen, Jan-Peter

2023

Volltextzugriff (PDF)

Kapitel 1 - Physiologische Grundlagen

Schmerzmedizin kompakt, 2023, p.1-6

Jansen, Jan-Peter

2023

Volltextzugriff (PDF)

Kapitel 14 - Begutachtung von Menschen mit chronischen Schmerzen

Schmerzmedizin kompakt, 2023, p.111-118

Jansen, Jan-Peter

2023

Volltextzugriff (PDF)

Kapitel 3 - Therapieverfahren

Schmerzmedizin kompakt, 2023, p.13-24

2023

Volltextzugriff (PDF)

Kapitel 8 - Neuropathische Schmerzen

Schmerzmedizin kompakt, 2023, p.53-57

2023

Volltextzugriff (PDF)

5 - Medikamentöse Schmerztherapie

Leitfaden Schmerzmedizin, 2022, p.143-281

Second Edition, 2022

Volltextzugriff (PDF)

Schmerztherapie mit Nicht-Opioiden: Welches Medikament für welchen Patienten?

Hausarzt, 2013-10, Vol.50 (17), p.30-32

Jansen, Jan-Peter

2013

Volltextzugriff (PDF)

Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting

Current medical research and opinion, 2010-05, Vol.26 (5), p.1119-1129

2010

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Englisch
(33)
Deutsch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(23)
Humans
(18)
Female
(13)
Male
(13)
Adult
(12)
Middle Aged
(12)
Double-Blind Method
(10)
Aged
(7)
Biological And Medical Sciences
(7)
Clinical Neurology
(7)
Migraine
(7)
Neurosciences & Neurology
(7)
Adolescent
(6)
Gene Expression
(6)
Headache
(6)
Analgesics, Opioid - Adverse Effects
(5)
Genes
(5)
Medical Sciences
(5)
Neurosciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain

Evaluation of guideline-adherent treatment in cluster headache

Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-label, Phase 3b/4 Trial

New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects

Changes in Health-Related Quality of Life in Patients with Therapy-Resistant Migraine during Treatment with Erenumab in an Ambulatory Care Setting

Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial

Cistus incanus (CYSTUS052) for treating patients with infection of the upper respiratory tract. A prospective, randomised, placebo-controlled clinical study

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

Schmerz lass nach: Eine Einführung in die moderne Schmerztherapie

A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/012) of Alvimopan for Opioid-Induced Bowel Dysfunction in Patients With Non-Cancer Pain

A Randomized, Blind Comparison of Remifentanil and Alfentanil During Anesthesia for Outpatient Surgery

Survey to evaluate diagnosis and management of headache in primary care: Headache Management Pattern programme

Efficacy, Tolerability and Safety of Oral Eletriptan and Ergotamine plus Caffeine (Cafergot®) in the Acute Treatment of Migraine: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Comparison

Real-world evidence on HRQoL of therapy-resistant migraine patients undergoing preventive treatment in an ambulatory care setting (P1-1.Virtual)

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: Results of a twelve‐week, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study

Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design

An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study

Kapitel 12 - Somatic Symptom Disorder – die somatische Belastungsstörung

Kapitel 1 - Physiologische Grundlagen

Kapitel 14 - Begutachtung von Menschen mit chronischen Schmerzen

Kapitel 3 - Therapieverfahren

Kapitel 8 - Neuropathische Schmerzen

5 - Medikamentöse Schmerztherapie

Schmerztherapie mit Nicht-Opioiden: Welches Medikament für welchen Patienten?

Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting

Suchergebnisse filtern